Form 4 Tracker
Stephen Michael Kelsey

President, Research and Development; Senior Advisor to the Chief Executive Officer · 5 filings · Latest: Sep 16, 2026

Revolution Medicines, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RVMD
Stephen Michael KelseySenior Advisor to the Chief Executive OfficerSep 16, 2026
Sale
$199.245,569$1.1M286,307
RVMD
Kelsey Stephen Michael—Sep 15, 2026
Proposed Sale
$203.775,415$1.1M—
RVMD
Stephen Michael KelseySenior Advisor to the Chief Executive OfficerSep 11, 2026
Sale
$202.3692,531$18.7M291,876
RVMD
Stephen Michael KelseySenior Advisor to the Chief Executive OfficerSep 11, 2026
Option Exercise
$41.7192,531$3.9M384,407
RVMD
STEPHEN KELSEY—Sep 11, 2026
Proposed Sale
$203.3592,531$18.8M—
RVMD
Stephen Michael KelseyPresident, Research and DevelopmentJun 16, 2026
Sale
$156.124,175$651.8K291,876
RVMD
Kelsey Stephen Michael—Jun 15, 2026
Proposed Sale
$153.874,071$626.4K—
RVMD
Stephen Michael KelseyPresident, Research and DevelopmentMar 17, 2026
Sale
$99.484,302$428.0K295,398
RVMD
Kelsey Stephen Michael—Mar 16, 2026
Proposed Sale
$99.593,901$388.5K—
RVMD
Kelsey Stephen Michael—Dec 15, 2025
Proposed Sale
$77.815,296$412.1K—
RVMD
Kelsey Stephen Michael—Sep 15, 2025
Proposed Sale
$46.555,296$246.5K—
RVMD
STEPHEN M. KELSEY—Sep 11, 2025
Proposed Sale
$40.45150,000$6.1M—
RVMD
Kelsey Stephen Michael—Jun 16, 2025
Proposed Sale
$40.793,732$152.2K—
RVMD
Kelsey Stephen Michael—Mar 17, 2025
Proposed Sale
$38.893,611$140.4K—
RVMD
Kelsey Stephen Michael—Dec 16, 2024
Proposed Sale
$44.934,604$206.9K—
RVMD
STEPHEN M. KELSEY—Nov 13, 2024
Proposed Sale
$59.3316,666$988.8K—
RVMD
STEPHEN M. KELSEY—Oct 14, 2024
Proposed Sale
$50.4816,666$841.3K—
RVMD
Kelsey Stephen Michael—Sep 16, 2024
Proposed Sale
$42.124,601$193.8K—
RVMD
STEPHEN M. KELSEY—Sep 13, 2024
Proposed Sale
$41.9716,667$699.5K—